Amedeo Smart

Free Medical Literature Service


 

Amedeo

Autoimmune Disorders

  Free Subscription

Articles published in
Curr Opin Immunol
    August 2021
  1. OIKONOMOU V, Break TJ, Gaffen SL, Moutsopoulos NM, et al
    Infections in the monogenic autoimmune syndrome APECED.
    Curr Opin Immunol. 2021;72:286-297.
    >> Share

    July 2021
  2. BIGLEY TM, Cooper MA
    Monogenic autoimmunity and infectious diseases: the double-edged sword of immune dysregulation.
    Curr Opin Immunol. 2021;72:230-238.
    >> Share

    June 2021
  3. SHIH HP, Ding JY, Yeh CF, Chi CY, et al
    Anti-interferon-gamma autoantibody-associated immunodeficiency.
    Curr Opin Immunol. 2021;72:206-214.
    >> Share

    April 2021
  4. STREETER HB, Wraith DC
    Manipulating antigen presentation for antigen-specific immunotherapy of autoimmune diseases.
    Curr Opin Immunol. 2021;70:75-81.
    >> Share

  5. CHARLES N
    Autoimmunity, IgE and FcepsilonRI-bearing cells.
    Curr Opin Immunol. 2021;72:43-50.
    >> Share

    January 2021
  6. CROWTHER MD, Sewell AK
    The burgeoning role of MR1-restricted T-cells in infection, cancer and autoimmune disease.
    Curr Opin Immunol. 2021;69:10-17.
    >> Share

    December 2020
  7. LA CAVA A
    Editorial overview: Research progress in autoimmunity: an overview and update.
    Curr Opin Immunol. 2020;67:iii-v.
    >> Share

    November 2020
  8. POSTAL M, Vivaldo JF, Fernandez-Ruiz R, Paredes JL, et al
    Type I interferon in the pathogenesis of systemic lupus erythematosus.
    Curr Opin Immunol. 2020;67:87-94.
    >> Share

  9. PLACE DE, Kanneganti TD
    The innate immune system and cell death in autoinflammatory and autoimmune disease.
    Curr Opin Immunol. 2020;67:95-105.
    >> Share

  10. MORONEY JB, Chupp DP, Xu Z, Zan H, et al
    Epigenetics of the antibody and autoantibody response.
    Curr Opin Immunol. 2020;67:75-86.
    >> Share

    October 2020
  11. PAWLAK M, Ho AW, Kuchroo VK
    Cytokines and transcription factors in the differentiation of CD4(+) T helper cell subsets and induction of tissue inflammation and autoimmunity.
    Curr Opin Immunol. 2020;67:57-67.
    >> Share

    September 2020
  12. LINCOLN MR, Axisa PP, Hafler DA
    Epigenetic fine-mapping: identification of causal mechanisms for autoimmunity.
    Curr Opin Immunol. 2020;67:50-56.
    >> Share

    August 2020
  13. MIKAMI N, Kawakami R, Sakaguchi S
    New Treg cell-based therapies of autoimmune diseases: towards antigen-specific immune suppression.
    Curr Opin Immunol. 2020;67:36-41.
    >> Share

  14. GALGANI M, Bruzzaniti S, Matarese G
    Immunometabolism and autoimmunity.
    Curr Opin Immunol. 2020;67:10-17.
    >> Share

    June 2020
  15. GREBINOSKI S, Vignali DA
    Inhibitory receptor agonists: the future of autoimmune disease therapeutics?
    Curr Opin Immunol. 2020;67:1-9.
    >> Share

    May 2020
  16. SHIPMAN WD, Sandoval MJ, Veiga K, Donlin LT, et al
    Fibroblast subtypes in tissues affected by autoimmunity: with lessons from lymph node fibroblasts.
    Curr Opin Immunol. 2020;64:63-70.
    >> Share

    December 2019
  17. SANZ I, Lund F
    Complexity and heterogeneity - the defining features of autoimmune disease.
    Curr Opin Immunol. 2019;61:iii-vi.
    >> Share

    November 2019
  18. BARNAS JL, Looney RJ, Anolik JH
    B cell targeted therapies in autoimmune disease.
    Curr Opin Immunol. 2019;61:92-99.
    >> Share

    October 2019
  19. CHANG HD, Tokoyoda K, Hoyer B, Alexander T, et al
    Pathogenic memory plasma cells in autoimmunity.
    Curr Opin Immunol. 2019;61:86-91.
    >> Share

  20. SILVERMAN GJ, Azzouz DF, Alekseyenko AV
    Systemic Lupus Erythematosus and dysbiosis in the microbiome: cause or effect or both?
    Curr Opin Immunol. 2019;61:80-85.
    >> Share

    September 2019
  21. ELLEBRECHT CT, Lundgren DK, Payne AS
    On the mark: genetically engineered immunotherapies for autoimmunity.
    Curr Opin Immunol. 2019;61:69-73.
    >> Share

  22. SLIGHT-WEBB S, Bourn RL, Holers VM, James JA, et al
    Shared and unique immune alterations in pre-clinical autoimmunity.
    Curr Opin Immunol. 2019;61:60-68.
    >> Share

  23. DHODAPKAR KM
    Autoimmune complications of cancer immunotherapy.
    Curr Opin Immunol. 2019;61:54-59.
    >> Share

    August 2019
  24. STEINMAN L, Ho PP, Robinson WH, Utz PJ, et al
    Antigen-specific tolerance to self-antigens in protein replacement therapy, gene therapy and autoimmunity.
    Curr Opin Immunol. 2019;61:46-53.
    >> Share

  25. THI CUC B, Pohar J, Fillatreau S
    Understanding regulatory B cells in autoimmune diseases: the case of multiple sclerosis.
    Curr Opin Immunol. 2019;61:26-32.
    >> Share

  26. TENG X, Cornaby C, Li W, Morel L, et al
    Metabolic regulation of pathogenic autoimmunity: therapeutic targeting.
    Curr Opin Immunol. 2019;61:10-16.
    >> Share

    July 2019
  27. SETH A, Craft J
    Spatial and functional heterogeneity of follicular helper T cells in autoimmunity.
    Curr Opin Immunol. 2019;61:1-9.
    >> Share

    March 2019
  28. FAHMY AM, Boulais J, Desjardins M, Matheoud D, et al
    Mitochondrial antigen presentation: a mechanism linking Parkinson's disease to autoimmunity.
    Curr Opin Immunol. 2019;58:31-37.
    >> Share

    February 2019
  29. CORSIERO E, Delvecchio FR, Bombardieri M, Pitzalis C, et al
    B cells in the formation of tertiary lymphoid organs in autoimmunity, transplantation and tumorigenesis.
    Curr Opin Immunol. 2019;57:46-52.
    >> Share

  30. DALMAS E
    Innate immune priming of insulin secretion.
    Curr Opin Immunol. 2019;56:44-49.
    >> Share

  31. COQUEL F, Neumayer C, Lin YL, Pasero P, et al
    SAMHD1 and the innate immune response to cytosolic DNA during DNA replication.
    Curr Opin Immunol. 2019;56:24-30.
    >> Share

    December 2018
  32. STETSON DB
    Editorial overview: Autoimmunity: A new frontier awaits.
    Curr Opin Immunol. 2018;55:iii-iv.
    >> Share

    November 2018
  33. RISTORI G, Faustman D, Matarese G, Romano S, et al
    Bridging the gap between vaccination with Bacille Calmette-Guerin (BCG) and immunological tolerance: the cases of type 1 diabetes and multiple sclerosis.
    Curr Opin Immunol. 2018;55:89-96.
    >> Share

    October 2018
  34. HALE M, Rawlings DJ, Jackson SW
    The long and the short of it: insights into the cellular source of autoantibodies as revealed by B cell depletion therapy.
    Curr Opin Immunol. 2018;55:81-88.
    >> Share

  35. PHALKE S, Marrack P
    Age (autoimmunity) associated B cells (ABCs) and their relatives.
    Curr Opin Immunol. 2018;55:75-80.
    >> Share

    September 2018
  36. OUKKA M, Bettelli E
    Regulation of lymphocyte trafficking in central nervous system autoimmunity.
    Curr Opin Immunol. 2018;55:38-43.
    >> Share

  37. JONES BE, Maerz MD, Buckner JH
    IL-6: a cytokine at the crossroads of autoimmunity.
    Curr Opin Immunol. 2018;55:9-14.
    >> Share

  38. MEDINA CO, Nagy N, Bollyky PL
    Extracellular matrix and the maintenance and loss of peripheral immune tolerance in autoimmune insulitis.
    Curr Opin Immunol. 2018;55:22-30.
    >> Share

  39. VOGELZANG A, Guerrini MM, Minato N, Fagarasan S, et al
    Microbiota - an amplifier of autoimmunity.
    Curr Opin Immunol. 2018;55:15-21.
    >> Share

    February 2018
  40. BOUDREAU JE, Hsu KC
    Natural killer cell education in human health and disease.
    Curr Opin Immunol. 2018;50:102-111.
    >> Share

    December 2017
  41. LO B, Lenardo MJ
    Editorial overview: Autoimmunity: New genomics approaches are improving our understanding of autoimmunity.
    Curr Opin Immunol. 2017;49:iv-vi.
    >> Share

    November 2017
  42. KRETSCHMER S, Lee-Kirsch MA
    Type I interferon-mediated autoinflammation and autoimmunity.
    Curr Opin Immunol. 2017;49:96-102.
    >> Share

  43. ROSE NR
    Negative selection, epitope mimicry and autoimmunity.
    Curr Opin Immunol. 2017;49:51-55.
    >> Share

    October 2017
  44. IVISON S, des Rosiers C, Lesage S, Rioux JD, et al
    Biomarker-guided stratification of autoimmune patients for biologic therapy.
    Curr Opin Immunol. 2017;49:56-63.
    >> Share

    September 2017
  45. DENDROU CA, Fugger L
    Immunomodulation in multiple sclerosis: promises and pitfalls.
    Curr Opin Immunol. 2017;49:37-43.
    >> Share

    August 2017
  46. ROMI F, Hong Y, Gilhus NE
    Pathophysiology and immunological profile of myasthenia gravis and its subgroups.
    Curr Opin Immunol. 2017;49:9-13.
    >> Share

    July 2017
  47. LIANG Y, Sarkar MK, Tsoi LC, Gudjonsson JE, et al
    Psoriasis: a mixed autoimmune and autoinflammatory disease.
    Curr Opin Immunol. 2017;49:1-8.
    >> Share

    April 2017
  48. WAN X, Unanue ER
    Unique features in the presentation of insulin epitopes in autoimmune diabetes: an update.
    Curr Opin Immunol. 2017;46:30-37.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016